Doxofylline Tablets IP 400 mg are pharmaceutical-grade tablets specifically formulated for the effective management of respiratory conditions such as asthma, chronic obstructive pulmonary disease (COPD), and bronchitis. Manufactured under stringent WHO-GMP compliant facilities by IndiGlobal Exports, these tablets ensure consistent therapeutic efficacy and precise dosing. The 400 mg dose of Doxofylline, a xanthine derivative, acts as a bronchodilator helping to relax airway muscles, improving breathing capacity in patients with obstructive airway diseases. Packaged in export-grade blister or strip packs, these tablets meet the highest international quality and regulatory standards suitable for global pharmaceutical markets. The product is designed for hospital use, retail pharmacies, and bulk institutional distribution where quality, safety, and dosage uniformity are critical for patient outcomes. Each batch undergoes rigorous testing to comply with Indian Pharmacopoeia (IP) and USP requirements, making it a reliable choice for therapeutic respiratory care worldwide.
Key Features
| Features | Description |
|---|---|
| Active Ingredient | Doxofylline 400 mg |
| Therapeutic Use | Management of respiratory diseases including asthma and COPD |
| Formulation Type | Tablet |
| Certification | Manufactured under WHO-GMP standards |
| Packaging | Export-grade blister or strip packs |
| Compliance | Indian Pharmacopoeia IP, USP standards |
| Manufacturer | IndiGlobal Exports |
| Dosage Accuracy | Consistent and precise dosing per tablet |
| Shelf Life | As per regulatory norms |
| Market Suitability | Ideal for international regulated and semi-regulated markets |
| Attributes | Description |
|---|---|
| Dosage Strength | 400 mg |
| Pharmacological Category | Bronchodilator, Respiratory therapeutic |
| Formulation | Tablet |
| Packaging Type | Blister/strip packs |
| Regulatory Standards | WHO-GMP, IP, USP |
| Intended Application | Clinical treatment of respiratory disorders |
| Manufacturing Site | GMP-compliant facilities |
| Intended Markets | Export markets with stringent quality control |
| Shelf Life Duration | As specified by regulatory authorities |
*Disclaimer: The above description has been AI-generated and has not been audited or verified for accuracy. It is recommended to verify product details independently before making any purchasing decisions.
Yes, the tablets are manufactured in WHO-GMP compliant facilities, packaged in export-grade blister or strip packs, and meet IP and USP standards, making them suitable for semi-regulated and regulated international markets.
Yes, the Doxofylline Tablets IP 400 mg strictly comply with Indian Pharmacopoeia (IP) and USP pharmacopoeial quality benchmarks.
The product is manufactured in GMP-compliant facilities adhering to WHO guidelines, ensuring consistent dosage, safety, and therapeutic efficacy.
The tablets are typically packaged in export-grade blister or strip packs, suitable for bulk institutional supply and easy transportation in global markets.
Yes, in tablet form with precise dosage, the product is ideal for hospital settings and retail pharmacies requiring easy administration and dosage consistency.
Brand: indiglobal exports
Country Of Origin: India
Doxofylline Tablets IP 400 mg is a pharmaceutical product indicated for respiratory treatment. This formulation is manufactured with export-quality standards to ensure therapeutic efficacy, consistent dosage, and compliance with international healthcare regulations.
Features:Doxofylline Tablets IP 400 mg is developed for the effective management of respiratory conditions, offering reliable performance backed by stringent pharmaceutical standards. Each batch is carefully produced and tested to ensure consistency, safety, and compliance with global export norms.
This formulation supports the clinical treatment and ongoing care of patients with respiratory indications. Commonly prescribed in hospital and retail pharmacy settings, it ensures measurable therapeutic benefit.
Crafted in state-of-the-art facilities, this tablet formulation ensures accuracy in dosing and ease of administration. It is typically available in secure blister or strip packs suitable for bulk export or institutional supply.
The product is manufactured in facilities adhering to WHO-GMP standards and complies with pharmacopoeial quality benchmarks (IP/USP). Ideal for regulated and semi-regulated markets seeking quality-assured medications.
Inclusive of all taxes
You Save: 0
Panchkula , India
Service Provider , Professional Services, Exporter, Wholesaler
GST- 06eogps3248l1zf
